Zydus Cadila’s dementia drug gets US FDA nod
The drug will be manufactured at the group’s formulations manufacturing facility at Moraiya in Ahmedabad
Zydus Cadila has…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Home » Latest Updates » Page 228
Browsing Category
Latest Updates
SC bars Malvinder, Shivinder Singh from selling Fortis shares
The restriction on the brothers from diluting their stake in the hospital chain will continue till October 31, the date fixed by…
DRL settles patent row with Vivus on weight management drug
The settlement permits DRL to begin selling a generic version of Qsymia from June 2025, or earlier under certain circumstances…
Arrow Pharmaceuticals acquires Amneal Pharmaceuticals in Australia
Arrow will incur an amount of AUD 17 million towards consideration, working capital and other estimated acquisition and…
NPPA, NADA app to help athletes identify prohibited medicines
The app will bridge the information asymmetry for athletes and help them to keep away from the prohibited substances
Drug pricing…
US FDA hikes fee for processing ANDA by $1 lakh for FY18
The hike was made under Generic Drug User Fee Amendments of 2017 (GDUFA II)
Citing high workload, the US Food and Drug…
Ajanta Pharma launches eletriptan hydrobromide tabs
Eletriptan hydrobromide tabs are indicated to treat headache
Ajanta Pharma has launched eletriptan hydrobromide tablets, used to…
IGMPI wins ASSOCHAM Services Excellence Award 2017
IGMPI was felicitated keeping in mind the fundamentally strong and resilient education and knowledge dissemination model
IGMPI…
DRL launches Cefixime for oral suspension
The drug is a generic version of Suprax, approved by the US FDA
Vyome Biosciences appoints Angelo Secci as Chief Medical Officer
He will be responsible for leading Vyome’s clinical development, including the clinical programme of lead molecule, VB 1953, for…